HPAIW vs AIRS vs SKIN vs AISP

For growth investors, Helport AI Limited (HPAIW) is the stronger pick with 132.

4% revenue growth year-over-year, versus -33. 5% for Airship AI Holdings, Inc. (AISP). Airship AI Holdings, Inc. (AISP) offers the better valuation at 3. 3x trailing P/E, making it the more compelling value choice. Analysts rate AirSculpt Technologies, Inc. (AIRS) a "Hold" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Airship AI Holdings, Inc.

(AISP) delivered a total return of -74. 3%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: AIRS returned -73. 1% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Helport AI Limited (HPAIW) is the lower-risk stock at -0.

11β versus AirSculpt Technologies, Inc. 's 2. 97β — meaning AIRS is approximately -2755% more volatile than HPAIW relative to the S&P 500. On balance sheet safety, Helport AI Limited (HPAIW) carries a lower debt/equity ratio of 37% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Helport AI Limited (HPAIW) is pulling ahead at 132.

4% versus -33. 5% for Airship AI Holdings, Inc. (AISP). On earnings-per-share growth, the picture is similar: Airship AI Holdings, Inc. grew EPS 140. 0% year-over-year, compared to -77. 4% for AirSculpt Technologies, Inc.. Over a 3-year CAGR, AIRS leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Airship AI Holdings, Inc.

(AISP) is the more profitable company, earning 1914% net margin versus -4. 6% for AirSculpt Technologies, Inc. — meaning it keeps 1914% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HPAIW leads at 31. 1% versus -47. 1% for AISP. At the gross margin level — before operating expenses — SKIN leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, AIRS (0.

1% yield) pays a dividend. HPAIW, SKIN, AISP do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Helport AI Limited (HPAIW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

11)). Airship AI Holdings, Inc. (AISP) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HPAIW: -77. 8%, AISP: -74. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HPAIW (Technology) and AIRS (Healthcare) and SKIN (Consumer Defensive) and AISP (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HPAIW is a small-cap high-growth stock; AIRS is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; AISP is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.